| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | Jan 3, 2025 | PUMA BIOTECHNOLOGY, INC. | Chief Commercial Officer | Sell | 32.5 | -9,437 | -7.97% | ✓ | $29.7K |
| Jul 17, 2024 | Jul 18, 2024 | PUMA BIOTECHNOLOGY, INC. | Chief Commercial Officer | Sell | 46.3 | -2,598 | -2.15% | ✓ | $9.6K |
| Jul 2, 2024 | Jul 2, 2024 | PUMA BIOTECHNOLOGY, INC. | Chief Commercial Officer | Sell | 41.3 | -6,051 | -4.76% | ✓ | $19.8K |
| Jan 3, 2024 | Jan 5, 2024 | PUMA BIOTECHNOLOGY, INC. | Chief Commercial Officer | Sell | 25.0 | -12,956 | -11.47% | ✓ | $58.1K |
| Jul 3, 2023 | Jul 6, 2023 | PUMA BIOTECHNOLOGY, INC. | Chief Commercial Officer | Sell | 32.5 | -12,103 | -9.68% | ✓ | $40.1K |
| Jan 3, 2023 | Jan 5, 2023 | PUMA BIOTECHNOLOGY, INC. | Chief Commercial Officer | Sell | 26.3 | -6,568 | -10.16% | ✗ | $27.4K |
| Jul 5, 2022 | Jul 7, 2022 | PUMA BIOTECHNOLOGY, INC. | Chief Commercial Officer | Sell | 26.3 | -5,835 | -8.28% | ✗ | $15.4K |
| Jan 3, 2022 | Jan 5, 2022 | PUMA BIOTECHNOLOGY, INC. | Chief Commercial Officer | Sell | 26.3 | -4,727 | -13.11% | ✗ | $15.1K |